Avapritinib
目录号: A19505
KIT and PDGFRA 抑制剂
Avapritinib(BLU-285)是一种高效、选择性强且口服生物利用度高的KIT和PDGFRA激活环突变激酶抑制剂,其半抑制浓度(IC50)分别为0.27纳摩尔(nM)针对KIT D816V和0.24纳摩尔(nM)针对PDGFRA D842V。
Discription | Avapritinib (BLU-285) is a highly potent, selective, and orally bioavailable KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A19505 |
---|---|
分子式 | C26H27FN10 |
分子量 | 498.56 |
CAS号 | 1703793-34-3 |
SMILES | CN1N=CC(C2=CN3C(C(N4CCN(C5=NC=C([C@@](C)(N)C6=CC=C(F)C=C6)C=N5)CC4)=NC=N3)=C2)=C1 |
其他名称 | BLU-285, BLU 285, BLU285 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 61 mg/mL (122.35 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL | ||
In vivo | 2% DMSO+40% PEG 300+2% Tween 80+ddH2O | 3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.06 mL | 100.29 mL | 200.58 mL |
0.5 mM | 4.01 mL | 20.06 mL | 40.12 mL |
1 mM | 2.01 mL | 10.03 mL | 20.06 mL |
5 mM | 0.4 mL | 2.01 mL | 4.01 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2